# Omega-3 Replacement With Krill Oil in Disease Management of SLE

> **NCT03626311** · NA · COMPLETED · sponsor: **Aker BioMarine Human Ingredients AS** · enrollment: 76 (actual)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DIETARY_SUPPLEMENT:** AKBM-3031
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03626311
- **Lead sponsor:** Aker BioMarine Human Ingredients AS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-23
- **Primary completion:** 2021-08-21
- **Final completion:** 2021-08-21
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03626311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03626311, "Omega-3 Replacement With Krill Oil in Disease Management of SLE". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03626311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*